Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Inflamm Res. 2013 Aug 22;62(11):10.1007/s00011-013-0657-5. doi: 10.1007/s00011-013-0657-5

TABLE 1.

Identification of potential PKCβ substrates in MCP-1-treated monocytes compared to PKCβ-specific antisense ODN treated monocytes.

Spot number Protein name NCBI accession number Mol. mass (kDa) Isoelectric point (pI) Number of peptides (%sequence coverage)
1 Vimentin
Tubulin, alpha
37582
13436317
54
50
5.0
4.9
33 (73%)
3 (11%)
2 Vimentin
ATP synthase, H+ transporting, mitochondrial F1 complex, beta peptide
37582
16741373
54
56
5.0
5.2
28 (54%)
18 (49%)
3 Vimentin
NF-M protein
37582
35046
54
102
5.0
4.9
29 (55%)
4 (4%)
4 Vimentin
Tubulin, alpha
7576229
13436317
54
50
5.0
4.9
46 (73%)
11 (31%)
5 Lamin B1 576840 66.6 5.1 18 (29%)
6 Lymphocyte cytosolic protein 1 (L-plastin) 8217500 71 5.3 13 (26%)
7 Capping protein gelsolin- like 60655417 39 5.8 14 (34%)
8 Capping protein gelsolin- like 60655417 39 5.8 14 (34%)
9 Annexin I
Aflatoxin aldehyde reductase AFAR
55959292
2736256
39
37
6.5
6.2
17 (47%)
2 (8%)
10 ENO1 (Enolase 1 variant) 62896593 47 7.0 25 (53%)
11 ENO1 (Enolase 1 variant)
Lasp-1 protein
29792061
2135552
47
31
7.0
6.1
6 (18%)
5 (18%)
12 Bilverdin reductase A
Transaldolase 1
13543489
14603290
34
38
6.0
6.3
6 (21%)
2 (5%)